CBSE Class 12 Maths: Chapter-Wise Exam Pattern & Marking Scheme The CBSE Class 12 Mathematics exam is divided into an 80-mark theory paper and a 20-mark internal assessment. The chapter-wise exam ...

Oct 29 (Reuters) - Indian carrier IndiGo (INGL.NS), opens new tab has not ruled out more interim solutions to increase its long-haul capacity before the wide-body jets it has ordered from Airbus ...

WYRYKI, Poland—After suspected Russian drones violated NATO airspace in recent weeks, closing airports and rattling citizens, European militaries and governments find themselves in a new era of ...

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Wednesday. Penguin Solutions reported quarterly earnings of 43 cents per share which beat the analyst ...

The 2025 Korn Ferry Tour season continues with the Compliance Solutions Championship, the penultimate tournament of the Tour's 26-event schedule and the third of four Korn Ferry Tour Finals events.

Mumbai-based insurtech platform Turtlemint Fintech Solutions has filed a Pre-Filed draft red herring prospectus with the SEBI and stock exchanges on September 4 to raise funds via an initial public ...

Offerpad Solutions Inc. (NYSE:OPAD) jumped 25% in Tuesday's pre-market session, rising to $1.50 after closing at $1.20 on Monday, according to Benzinga Pro data. Check out the current price of OPAD ...

Atlassian CEO and co-founder Mike Cannon-Brookes sent the video titled “Restructuring the CSS Team: A Difficult Decision for Our Future” to staff on Wednesday morning (30 July), informing them that ...

BeyondTrust has released security updates to fix a high-severity flaw in its Remote Support (RS) and Privileged Remote Access (PRA) solutions that can let unauthenticated attackers gain remote code ...

NEW HANOVER COUNTY, N.C. (WECT) - After a long, heated debate among New Hanover County Commissioners Thursday, county leaders walked away with the next fiscal year’s budget approved, but millions in ...

Approval of Zusduri was based on data from the Phase III ENVISION trial, which showed a 78% complete response at three months in patients with recurrent low-grade, intermediate-risk non-muscle ...